Comparative study of diclofenac sodium and flurbiprofen in osteoarthritis

Journal of the Pakistan Medical Association

Volumn 46, Issue 12, 1996, Pages 270-272

  Shaikh, Khalil Ahmad ^a  

^a DOW UNIVERSITY OF HEALTH SCIENCES   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

DICLOFENAC; FLURBIPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; DYSPEPSIA; EPIGASTRIC PAIN; FEMALE; FLATULENCE; HEARTBURN; HUMAN; MALE; ORAL DRUG ADMINISTRATION; OSTEOARTHRITIS; RANDOMIZED CONTROLLED TRIAL; SYMPTOMATOLOGY;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DICLOFENAC; FEMALE; FLURBIPROFEN; HUMANS; MALE; OSTEOARTHRITIS;

EID: 0030443648     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. David. Y., Grahm, M.D., Richard, H. et al. The misoprostal study groups, duodenal and gastric ulcer prevention with misoprostal in arthritis patients taking NSAIDS. Ann. Intern. Med., 1993;119:257-8.
2. Goldie, I.F. Piroxicam and naprosyn in osteoarthritis: clinical comparison. Eur. J. Rheumatol. Inflam., 1981;4:348-356.
3. Huskinson, E.G. Measurement of pain. Lancet, 1974;2:1127-1131.
4. Lister, B.J., Poland, M. and Delapp, R.E. Efficacy of nabumeton versus diclofenac. Am. J.Med., 1993;95:25-95.